Caribou Biosciences (CRBU) Treasury Shares (2022 - 2026)

Caribou Biosciences (CRBU) has 5 years of Treasury Shares data on file, last reported at $3.0 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $3.0 million, up 36.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (up 36.16% YoY), and the FY2025 annual result was $2.2 million, up 67.52% from the prior year.
• Treasury Shares grew to $3.0 million in Q1 2026 per CRBU's latest filing, from $2.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $3.0 million in Q1 2026 and troughed at $60000.0 in Q1 2022.
• A 5-year average of $1.1 million and a median of $1.2 million in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares slumped 35.16% in 2023, then surged 673.49% in 2024.
• A 5-year view of Treasury Shares shows it stood at $256146.0 in 2022, then decreased by 19.83% to $205357.0 in 2023, then soared by 531.74% to $1.3 million in 2024, then surged by 67.52% to $2.2 million in 2025, then surged by 38.95% to $3.0 million in 2026.
• Business Quant data shows CRBU's Treasury Shares at $3.0 million in Q1 2026, $2.2 million in Q4 2025, and $2.2 million in Q3 2025.